Cargando…

A new emergency in oncology: Bone metastases in breast cancer patients (Review)

Breast cancer (BC) is the most common tumour in females and as a result, the management of such patients is a major public health issue. A high percentage of BC patients develop bone metastases (BMs), occasionally even several years following the initial diagnosis. BMs are responsible for high morbi...

Descripción completa

Detalles Bibliográficos
Autores principales:	IBRAHIM, TONI, MERCATALI, LAURA, AMADORI, DINO
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789111/ https://www.ncbi.nlm.nih.gov/pubmed/24137321 http://dx.doi.org/10.3892/ol.2013.1372

Ejemplares similares

RANK/RANK-L/OPG in Patients with Bone Metastases Treated with Anticancer Agents and Zoledronic Acid: A Prospective Study
por: Mercatali, Laura, et al.
Publicado: (2013)

Osteoblastic bone metastases from neuroendocrine tumor (NET) of unknown origin detected by (18)fluorocholine PET/CT and its comparison with (68)gallium-DOTATOC PET/CT: Case report and review of the literature
por: Bongiovanni, Alberto, et al.
Publicado: (2017)

The Effect of Everolimus in an In Vitro Model of Triple Negative Breast Cancer and Osteoclasts
por: Mercatali, Laura, et al.
Publicado: (2016)

Tumor-Stroma Crosstalk in Bone Tissue: The Osteoclastogenic Potential of a Breast Cancer Cell Line in a Co-Culture System and the Role of EGFR Inhibition
por: Mercatali, Laura, et al.
Publicado: (2017)

Splicing factor ratio as an index of epithelial-mesenchymal transition and tumor aggressiveness in breast cancer
por: Fici, Pietro, et al.
Publicado: (2016)

Inhibition of breast cancer cell proliferation in repeated and non-repeated treatment with zoledronic acid
por: Ibrahim, Toni, et al.
Publicado: (2012)

Primary leiomyosarcoma of the bone: a case report and a review of the literature
por: Recine, Federica, et al.
Publicado: (2017)

Development of a Patient-Derived Xenograft (PDX) of Breast Cancer Bone Metastasis in a Zebrafish Model
por: Mercatali, Laura, et al.
Publicado: (2016)

Current classification, treatment options, and new perspectives in the management of adipocytic sarcomas
por: De Vita, Alessandro, et al.
Publicado: (2016)

Management and potentialities of primary cancer cultures in preclinical and translational studies
por: Miserocchi, Giacomo, et al.
Publicado: (2017)

New Ground-Breaking Strategies in Bone Regeneration—In Memory of Nerio Ceroni
por: De Vita, Alessandro, et al.
Publicado: (2022)

A biomimetic 3D model of hypoxia-driven cancer progression
por: Liverani, Chiara, et al.
Publicado: (2019)

Comment on ‘Reorganisation of medical oncology departments during the novel coronavirus disease-19 pandemic: A nationwide Italian survey’ by Alice Indini et al.
por: Bongiovanni, Alberto, et al.
Publicado: (2020)

Update on the role of trabectedin in the treatment of intractable soft tissue sarcomas
por: Recine, Federica, et al.
Publicado: (2017)

Vitamin D receptor polymorphisms or serum levels as key drivers of breast cancer development? The question of the vitamin D pathway
por: Amadori, Dino, et al.
Publicado: (2017)

First-line chemotherapy in patients with metastatic gastroenteropancreatic neuroendocrine carcinoma
por: Bongiovanni, Alberto, et al.
Publicado: (2015)

Lineage‐specific mechanisms and drivers of breast cancer chemoresistance revealed by 3D biomimetic culture
por: Liverani, Chiara, et al.
Publicado: (2021)

Breast cancer bone metastases: an orthopedic emergency
por: Piccioli, Andrea
Publicado: (2013)

Elf5 inhibits epithelial mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2/Slug
por: Chakrabarti, Rumela, et al.
Publicado: (2012)

Activity of Eribulin in a Primary Culture of Well-Differentiated/Dedifferentiated Adipocytic Sarcoma
por: De Vita, Alessandro, et al.
Publicado: (2016)

Immune Checkpoint Inhibitors With or Without Bone-Targeted Therapy in NSCLC Patients With Bone Metastases and Prognostic Significance of Neutrophil-to-Lymphocyte Ratio
por: Bongiovanni, Alberto, et al.
Publicado: (2021)

Myxofibrosarcoma primary cultures: molecular and pharmacological profile
por: De Vita, Alessandro, et al.
Publicado: (2017)

Metastatic neuroendocrine neoplasia treatments in patients over 70 years of age
por: Bongiovanni, Alberto, et al.
Publicado: (2018)

ΔNp63 promotes stem cell activity in mammary gland development and basal-like breast cancer by enhancing Fzd7 expression and Wnt signaling
por: Chakrabarti, Rumela, et al.
Publicado: (2014)

Primary Culture of Undifferentiated Pleomorphic Sarcoma: Molecular Characterization and Response to Anticancer Agents
por: De Vita, Alessandro, et al.
Publicado: (2017)

Long-lasting activity of trabectedin in refractory uterine leiomyosarcoma: a case report
por: Bongiovanni, Alberto, et al.
Publicado: (2015)

Metronomic capecitabine in gastroenteropancreatic neuroendrocrine tumors: a suitable regimen and review of the literature
por: Bongiovanni, Alberto, et al.
Publicado: (2014)

Perfusion Flow Enhances Viability and Migratory Phenotype in 3D-Cultured Breast Cancer Cells
por: Pasini, Alice, et al.
Publicado: (2021)

Characteristics of Breast Cancer Metastasizing to Bone in a Mediterranean Population
por: Bannoura, Sami, et al.
Publicado: (2020)

The failures and challenges of bone metastases research in radiation oncology
por: Bedard, Gillian, et al.
Publicado: (2013)

Moving forward with new data and approaches: a fresh look at anthracyclines in non-Hodgkin's lymphoma
por: Amadori, Dino
Publicado: (2011)

Development of an evidence-based educational resource in oncology: ‘Living safely with bone metastases’
por: Ibrahim, Marize, et al.
Publicado: (2022)

An in-silico study of cancer cell survival and spatial distribution within a 3D microenvironment
por: Cortesi, Marilisa, et al.
Publicado: (2020)

Bisphosphonates in oncology: evidence for the prevention of skeletal events in patients with bone metastases
por: Polascik, Thomas J
Publicado: (2009)

Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization
por: Korpal, Manav, et al.
Publicado: (2011)

Androgen Receptor Expression in Breast Cancer: What Differences Between Primary Tumor and Metastases?
por: Bronte, Giuseppe, et al.
Publicado: (2018)

Immunohistochemical Predictors of Bone Metastases in Breast Cancer Patients
por: Winczura, Piotr, et al.
Publicado: (2015)

Bone-Targeted Agents for the Management of Breast Cancer Patients with Bone Metastases
por: Simos, Demetrios, et al.
Publicado: (2013)

Acid-Induced Inflammatory Cytokines in Osteoblasts: A Guided Path to Osteolysis in Bone Metastasis
por: Di Pompo, Gemma, et al.
Publicado: (2021)

Prevention and Treatment of Bone Metastases in Breast Cancer
por: Carla, Ripamonti, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ps5d5u4ovgcnpbbvd3thlqps3f